NASDAQ:NBTX
Nanobiotix S.A. Stock News
$6.00
+0.160 (+2.74%)
At Close: May 01, 2024
Nanobiotix S.A. (NBTX) Q4 2023 Earnings Call Transcript
11:51am, Saturday, 27'th Apr 2024
Nanobiotix S.A. (NASDAQ:NBTX ) Q4 2023 Earnings Conference Call April 25, 2024 8:00 AM ET Company Participants Craig West - Senior Vice President, Investor Relations Laurent Levy - Co-Founder and Chie
NANOBIOTIX to Announce Fourth Quarter and Full Year 2023 Operational and Financial Update on April 24, 2024
04:15pm, Wednesday, 17'th Apr 2024
Conference call and webcast scheduled for Thursday, April 25, 2024, at 8:00 am EDT / 2:00 pm. CEST Conference call and webcast scheduled for Thursday, April 25, 2024, at 8:00 am EDT / 2:00 pm. CEST
Nanobiotix to Present at Upcoming Investor Conferences in March
04:15pm, Wednesday, 06'th Mar 2024
PARIS and CAMBRIDGE, Mass., March 06, 2024 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO –– NASDAQ: NBTX – the ‘‘Company''), a late-clinical stage biotechnology company pioneering physics-b
Nanobiotix to Present at the Guggenheim 6th Annual Biotechnology Conference
04:15pm, Wednesday, 31'st Jan 2024
PARIS and CAMBRIDGE, Mass., Jan. 31, 2024 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO –– NASDAQ: NBTX – the ‘‘Company''), a late-clinical stage biotechnology company pioneering physics-ba
Nanobiotix S.A. (NBTX) Q3 2023 Earnings Call Transcript
01:01pm, Tuesday, 14'th Nov 2023
Nanobiotix S.A. (NASDAQ:NBTX ) Q3 2023 Earnings Conference Call November 14, 2023 8:00 AM ET Company Participants Craig West - Senior Vice President of Investor Relations Laurent Levy - Co-Founder and
NANOBIOTIX to Announce Third Quarter 2023 Operational and Financial Update on November 13, 2023
04:15pm, Thursday, 09'th Nov 2023
Conference call and webcast scheduled for Tuesday, November 14, 2023, at 2:00 pm. CET / 8:00 am ET Conference call and webcast scheduled for Tuesday, November 14, 2023, at 2:00 pm. CET / 8:00 am ET
Nanobiotix S.A. (NBTX) Q2 2023 Earnings Call Transcript
10:52am, Wednesday, 27'th Sep 2023
Nanobiotix S.A. (NASDAQ:NBTX ) Q2 2023 Earnings Conference Call September 27, 2023 8:00 AM ET Company Participants Craig West - SVP, IR Laurent Levy - Co-Founder & CEO Bart Van Rhijn - CFO Conference
Nanobiotix to Announce Half Year 2023 Financial Results on September 26, 2023
04:15pm, Tuesday, 19'th Sep 2023
Conference Call and Webcast to be Held at 8:00 AM EDT / 2:00 PM CEST on September 27, 2023 Conference Call and Webcast to be Held at 8:00 AM EDT / 2:00 PM CEST on September 27, 2023
NANOBIOTIX to Present at the H.C. Wainwright 25th Annual Global Investment Conference
04:15pm, Thursday, 31'st Aug 2023
PARIS and CAMBRIDGE, Mass., Aug. 31, 2023 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO –– NASDAQ: NBTX – the ‘‘Company''), a late-clinical stage biotechnology company pioneering physics-ba
Nanobiotix: At A Crucial Juncture For Data
08:40am, Thursday, 24'th Aug 2023
Nanobiotix is an oncology-focused biotech aiming for its first drug approval, with a tripled value since the beginning of 2023. Their flagship molecule, NBTX3-RT, is showing promising results in enhan
Nanobiotix surges on commercialization deal with J&J's Janssen for cancer therapeutic
01:11pm, Monday, 10'th Jul 2023
French biotechnology company Nanobiotix has entered into an agreement with J&J's wholly-owned medical research and pharmaceutical arm Janssen to license, co-develop and commercialize a drug to treat h
Nanobiotix ADRs Jump Over 50% After Agreement With J&J's Janssen Pharmaceutical
10:40am, Monday, 10'th Jul 2023
American depositary receipts of Nanobiotix jumped over 50% in early trading on Monday after signing an agreement with J&J's Janssen Pharmaceutical to work on co-developing a drug to treat head and nec
Nanobiotix's stock soars after entering licensing, development deal with J&J's Janssen Pharmaceutica
06:14am, Monday, 10'th Jul 2023
Shares of Nanobiotix SA NBTX, +1.57% shot up 52.1% toward a 17-month high in premarket trading Monday, after the France-based biotechnology company announced a global licensing and co-development agre
Nanobiotix stock skyrockets on final negotiations with ‘major' drug maker for its cancer treatment
12:56pm, Friday, 05'th May 2023
Nanobiotix SA (EPA:NANO) shares soared 250% to $7.11, on volume of more than 29 million shares, Friday after the France-based clinical biotechnology company said it has entered into final contract ne
The U.S.-listed shares of Nanobiotix S.A. NBTX blasted 221.7% higher on massive volume Friday, to pace all gainers trading on major U.S. exchanges, after the France-based biotechnology company said it
